IRIS
CARLOMAGNO, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.078
Totale 4.078
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.078
Totale 4.078
Salva come PNG Salva come JPEG
Città #
Genova 3.121
Rapallo 431
Genoa 397
Vado Ligure 115
Bordighera 14
Totale 4.078
Salva come PNG Salva come JPEG
Nome #
NK/DC crosstalk in anti-viral response. 155
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 154
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 151
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 145
NK cells and their receptors during viral infections. 139
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 138
Bridging innate NK cell Functions with Adaptive Immunity. 135
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 134
Features of Memory-Like and PD-1+ Human NK Cell Subsets 128
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 127
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2 126
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 124
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 122
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 121
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 116
Natural killer lymphocytes: "null cells" no more. 115
Human NK cell response to pathogens 112
TLR/NCR/KIR: Which One to Use and When? 107
Natural killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT 106
Natural Killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT. 101
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 100
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 94
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function 94
NK Cell-Based Immunotherapy for Hematological Malignancies 86
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 80
CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells 80
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 79
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 79
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 78
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 74
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 73
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 71
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 67
The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells 66
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. 59
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 59
The tryptophan catabolite L-Kynurenine affects human NK cell function 56
NK Cell-Based Immunotherapy in Colorectal Cancer 52
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer 48
NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles 48
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 48
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts 40
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma 36
Natural killer cell impairment in ovarian clear cell carcinoma 24
NK/DC crosstalk in anti-viral response 23
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 20
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 14
Anti-CD94-induced expansion of highly functional adaptive NKG2C+NKG2A−CD57+selfKIR+ NK cells from CMV-seropositive healthy donors 8
Totale 4.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.355
article - articoli 11.567
book - libri 0
conference - conferenze 1.509
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 279
Totale 26.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.111 0 0 39 87 125 134 160 86 119 200 121 40
2020/2021451 29 28 26 24 28 82 30 26 53 60 27 38
2021/2022580 15 44 61 45 19 31 41 135 28 62 31 68
2022/2023521 48 48 10 51 66 93 1 44 101 4 47 8
2023/2024325 19 41 8 45 33 26 17 29 24 27 12 44
2024/2025121 24 67 30 0 0 0 0 0 0 0 0 0
Totale 4.212